CYP2D6 genotype and optimization of breast cancer treatment

被引：0

作者：

Bandres, F. ^{[1
]}

Chicharro, L. M. ^{[2
]}

Tejerina, A. ^{[1
]}

del Saz, M. ^{[2
]}

Fernaacutendez-Santander, A. ^{[2
]}

机构：

[1] Fdn Tejerina, Unidad Docente, Madrid, Spain

[2] Univ Europea Madrid, Madrid, Spain

来源：

EJC SUPPLEMENTS | 2010年 / 8卷 / 03期

关键词：

D O I：

10.1016/S1359-6349(10)70446-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：179 / 179

页数：1

共 50 条

[31] CYP2D6 and tamoxifen: DNA matters in breast cancer [J].

Janelle M. Hoskins ;

Lisa A. Carey ;

Howard L. McLeod .

Nature Reviews Cancer, 2009, 9 :576-586

[32] CYP2D6 and tamoxifen: DNA matters in breast cancer [J].

Hoskins, Janelle M. ;

Carey, Lisa A. ;

Mcleod, Howard L. .

NATURE REVIEWS CANCER, 2009, 9 (08) :576-586

[33] CYP2D6 tamoxifen: Pharmacogenetics in early breast cancer [J].

Brauch H. ;

Schroth W. .

Der Gynäkologe, 2010, 43 (7) :579-585

[34] Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen [J].

Chan, Carmen W. H. ;

Law, Bernard M. H. ;

So, Winnie K. W. ;

Chow, Ka Ming ;

Waye, Mary M. Y. .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (06) :1395-1404

[35] Effect of CYP2D6 polymorphisms on breast cancer recurrence [J].

Morrow, Phuong K. ;

Serna, Ruben ;

Broglio, Kristine ;

Pusztai, Lajos ;

Nikoloff, D. Michelle ;

Hillman, Grantland R. ;

Fontecha, Marcel ;

Li, Rui ;

Michaud, Laura ;

Hortobagyi, Gabriel ;

Gonzalez-Angulo, Ana M. .

CANCER, 2012, 118 (05) :1221-1227

[36] Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen [J].

Carmen W. H. Chan ;

Bernard M. H. Law ;

Winnie K. W. So ;

Ka Ming Chow ;

Mary M. Y. Waye .

Journal of Cancer Research and Clinical Oncology, 2020, 146 :1395-1404

[37] CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy [J].

Thompson, A. M. ;

Bray, S. ;

Johnson, A. M. ;

Quinlan, P. ;

Nikloff, D. M. ;

Evans, D. G. ;

Clarke, R. ;

Lawrence, H. J. ;

Howell, A. ;

Latif, A. ;

Ferraldeschl, R. ;

Hillman, G. ;

Fontecha, M. ;

Newman, W. G. .

BREAST CANCER RESEARCH, 2010, 12 :S15-S15

[38] CYP2D6 Genotype Should Not Be Used for Deciding About Tamoxifen Therapy in Postmenopausal Breast Cancer [J].

Rae, James M. ;

Regan, Meredith ;

Leyland-Jones, Brian ;

Hayes, Daniel F. ;

Dowsett, Mitch .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) :2753-2755

[39] CYP2D6 Genotype and Tamoxifen Response for Breast Cancer: A Systematic Review and Meta-Analysis [J].

Lum, Danny W. K. ;

Perel, Pablo ;

Hingorani, Aroon D. ;

Holmes, Michael V. .

PLOS ONE, 2013, 8 (10)

[40] CYP2D6 Genotype Should Not Be Used to Determine Endocrine Therapy in Postmenopausal Breast Cancer Patients [J].

Rae, J. M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) :181-184

← 1 2 3 4 5 →